Augurex Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $5M

  • Investors
  • 5

Augurex General Information

Description

Developer of biomarker-based clinical diagnostics designed to improve patient outcomes in autoimmune diseases. The company develops novel diagnostic tests that use biomarkers to enable early and accurate diagnosis, prognosis, and ongoing management of inflammatory autoimmune conditions such as rheumatoid arthritis and axial spondyloarthritis, helping healthcare providers personalise treatment plans, improve patient outcomes, and reduce the burden of chronic disease.

Contact Information

Website
www.augurex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 887 Great Northern Way
  • Suite 220
  • Vancouver, British Columbia V5T 4T5
  • Canada
+1 (604)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 887 Great Northern Way
  • Suite 220
  • Vancouver, British Columbia V5T 4T5
  • Canada
+1 (604)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Augurex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 14-Mar-2024 $5M Completed Generating Revenue
6. Later Stage VC 25-Jan-2017 Completed Generating Revenue
5. Angel (individual) 01-Feb-2011 Completed Startup
4. Angel (individual) 01-May-2009 Completed Startup
3. Angel (individual) 01-Nov-2007 Completed Startup
2. Grant 01-Jan-2007 $52.8K Completed Startup
1. University Spin-Out 01-Jan-2007 Completed Startup
To view Augurex’s complete valuation and funding history, request access »

Augurex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biomarker-based clinical diagnostics designed to improve patient outcomes in autoimmune diseases. The compa
Diagnostic Equipment
Vancouver, Canada
21 As of 2026

Ann Arbor, MI
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Augurex Competitors (9)

One of Augurex’s 9 competitors is ONL Therapeutics, a Venture Capital-Backed company based in Ann Arbor, MI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ONL Therapeutics Venture Capital-Backed Ann Arbor, MI
Adverum Biotechnologies Formerly VC-backed Redwood City, CA
BioTissue (Biotechnology) Venture Capital-Backed Miami, FL
Gradalis Private Equity-Backed Carrollton, TX
Rein Therapeutics Formerly VC-backed Austin, TX
You’re viewing 5 of 9 competitors. Get the full list »

Augurex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Augurex Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Government of Canada Limited Partner
Genome British Columbia Not-For-Profit Venture Capital Minority
WUTIF Capital Angel Group Minority
New Ventures BC Accelerator/Incubator
The University of British Columbia University
To view Augurex’s complete investors history, request access »

Augurex FAQs

  • When was Augurex founded?

    Augurex was founded in 2007.

  • Where is Augurex headquartered?

    Augurex is headquartered in Vancouver, Canada.

  • What is the size of Augurex?

    Augurex has 21 total employees.

  • What industry is Augurex in?

    Augurex’s primary industry is Diagnostic Equipment.

  • Is Augurex a private or public company?

    Augurex is a Private company.

  • What is Augurex’s current revenue?

    The current revenue for Augurex is .

  • How much funding has Augurex raised over time?

    Augurex has raised $5.12M.

  • Who are Augurex’s investors?

    Government of Canada, Genome British Columbia, WUTIF Capital, New Ventures BC, and The University of British Columbia have invested in Augurex.

  • Who are Augurex’s competitors?

    ONL Therapeutics, Adverum Biotechnologies, BioTissue (Biotechnology), Gradalis, and Rein Therapeutics are some of the 9 competitors of Augurex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process